Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OGFR mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of OGFR mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of OGFR mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGFR mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Estradiol results in increased expression of OGFR mRNA | CTD | PMID:23019147 | 17beta-estradiol | increases phosphorylation | ISO | OGFR (Homo sapiens) | 6480464 | Estradiol results in increased phosphorylation of OGFR protein | CTD | PMID:27026707 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Ogfr (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OGFR mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to OGFR promoter] | CTD | PMID:17942748 and PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ogfr (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OGFR mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of OGFR mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of OGFR mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | OGFR (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of OGFR mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | bisphenol S results in increased expression of OGFR protein | CTD | PMID:34186270 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of OGFR mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of OGFR mRNA | CTD | PMID:31881176 | acrolein | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OGFR mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of OGFR mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of OGFR mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Tretinoin results in increased expression of OGFR mRNA | CTD | PMID:16054129 and PMID:33167477 | alpha-pinene | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OGFR mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of OGFR mRNA | CTD | PMID:32699268 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of OGFR mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of OGFR mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of OGFR mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of OGFR mRNA | CTD | PMID:33212167 | atrazine | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Atrazine results in increased expression of OGFR mRNA | CTD | PMID:22378314 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of OGFR mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of OGFR protein | CTD | PMID:34186270 | Bisphenol B | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | bisphenol B results in increased expression of OGFR protein | CTD | PMID:34186270 | bortezomib | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of OGFR mRNA | CTD | PMID:20977926 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of OGFR mRNA | CTD | PMID:33453195 | caffeine | decreases phosphorylation | ISO | OGFR (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of OGFR protein | CTD | PMID:35688186 | cannabidiol | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of OGFR mRNA | CTD | PMID:27918106 | carbon nanotube | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of OGFR mRNA | CTD | PMID:37019170 | cisplatin | increases phosphorylation | ISO | Ogfr (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of OGFR protein | CTD | PMID:22006019 | clofibrate | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of OGFR mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OGFR mRNA] | CTD | PMID:17585979 | clofibrate | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Clofibrate results in decreased expression of OGFR mRNA | CTD | PMID:17585979 | cobalt dichloride | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | cobaltous chloride results in increased expression of OGFR mRNA | CTD | PMID:21139344 | coumarin | decreases phosphorylation | ISO | OGFR (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of OGFR protein | CTD | PMID:35688186 | cyclosporin A | decreases methylation | ISO | OGFR (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of OGFR promoter | CTD | PMID:27989131 | doxorubicin | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of OGFR mRNA | CTD | PMID:29803840 | elemental selenium | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Selenium results in increased expression of OGFR mRNA | CTD | PMID:19244175 | enzyme inhibitor | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of OGFR protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Ogfr (Mus musculus) | 6480464 | Ethanol affects the splicing of OGFR mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Fenthion results in decreased expression of OGFR mRNA | CTD | PMID:34813904 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of OGFR mRNA | CTD | PMID:24136188 | FR900359 | affects phosphorylation | ISO | OGFR (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of OGFR protein | CTD | PMID:37730182 | genistein | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Genistein results in increased expression of OGFR mRNA | CTD | PMID:23019147 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of OGFR mRNA | CTD | PMID:22061828 | ivermectin | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of OGFR protein | CTD | PMID:32959892 | leflunomide | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | leflunomide results in decreased expression of OGFR mRNA | CTD | PMID:28988120 | lipopolysaccharide | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of OGFR protein | CTD | PMID:30501627 | methidathion | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | methidathion results in decreased expression of OGFR mRNA | CTD | PMID:34813904 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of OGFR mRNA | CTD | PMID:30047161 | methotrexate | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of OGFR mRNA | CTD | PMID:24449571 | naltrexone | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | Naltrexone results in increased expression of OGFR | CTD | PMID:21685240 | ozone | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OGFR mRNA more ... | CTD | PMID:32699268 and PMID:35430440 | paracetamol | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of OGFR mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of OGFR mRNA] | CTD | PMID:17585979 | paracetamol | affects expression | ISO | Ogfr (Mus musculus) | 6480464 | Acetaminophen affects the expression of OGFR mRNA | CTD | PMID:17562736 | pentachlorophenol | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of OGFR mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ogfr (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OGFR mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of OGFR mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of OGFR protein | CTD | PMID:37422089 | resveratrol | increases expression | ISO | Ogfr (Mus musculus) | 6480464 | resveratrol results in increased expression of OGFR protein | CTD | PMID:25505154 | selenium atom | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA | CTD | PMID:19244175 | selenium atom | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Selenium results in increased expression of OGFR mRNA | CTD | PMID:19244175 | silicon dioxide | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of OGFR mRNA | CTD | PMID:25351596 | silver atom | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Silver results in decreased expression of OGFR mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Silver results in decreased expression of OGFR mRNA | CTD | PMID:27131904 | sodium arsenite | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of OGFR protein | CTD | PMID:21925251 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of OGFR mRNA | CTD | PMID:30047161 | sunitinib | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Sunitinib results in increased expression of OGFR mRNA | CTD | PMID:31533062 | testosterone enanthate | affects expression | ISO | OGFR (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of OGFR mRNA | CTD | PMID:17440010 | triadimefon | decreases expression | EXP | | 6480464 | triadimefon results in decreased expression of OGFR mRNA | CTD | PMID:30047161 | urethane | decreases expression | ISO | OGFR (Homo sapiens) | 6480464 | Urethane results in decreased expression of OGFR mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | Ogfr (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of OGFR mRNA | CTD | PMID:21427059 | valproic acid | increases methylation | ISO | OGFR (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of OGFR gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of OGFR mRNA | CTD | PMID:23034163 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of OGFR gene | CTD | PMID:31079544 | vitamin E | multiple interactions | ISO | OGFR (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA | CTD | PMID:19244175 | vitamin E | increases expression | ISO | OGFR (Homo sapiens) | 6480464 | Vitamin E results in increased expression of OGFR mRNA | CTD | PMID:19244175 | |